Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis

Journal of Neurochemistry

Volumn 129, Issue 4, 2014, Pages 696-703

  Boullerne, Anne I ^a   Polak, Paul E ^a   Braun, David ^a   Sharp, Anthony ^b   Pelligrino, Dale ^a   Feinstein, Douglas L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

acute; chronic; EAE; multiple sclerosis; myelin oligodendrocyte glycoprotein; trifluoroacetate

Indexed keywords

ACETIC ACID; COUNTERION; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN A; MYELIN OLIGODENDROCYTE GLYCOPROTEIN B; PEPTIDE; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; IMMUNIZATION; MORBIDITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

MUS;

ACUTE; CHRONIC; EAE; MULTIPLE SCLEROSIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRIFLUOROACETATE;

ACETATES; AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; CHEMICAL FRACTIONATION; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG CONTAMINATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNIZATION; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TRIFLUOROACETIC ACID; VACCINES, SYNTHETIC;

EID: 84899482222     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12664     Document Type: Article

References (39)

1. Abo S., Bernard C. C., Webb M., Johns T. G., Alafaci A., Ward L. D., Simpson R. J., and, de Kerlero R. N., (1993) Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem. Mol. Biol. Int. 30, 945-958. (Pubitemid 23259032)
2. Amor S., Groome N., Linington C., Morris M. M., Dornmair K., Gardinier M. V., Matthieu J. M., and, Baker D., (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153, 4349-4356. (Pubitemid 24346829)
3. Berard J. L., Wolak K., Fournier S., and, David S., (2010) Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia 58, 434-445.
4. Cornish J., Callon K. E., Lin C. Q., Xiao C. L., Mulvey T. B., Cooper G. J., and, Reid I. R., (1999) Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am. J. Physiol. 277, E779-E783.
5. Feinstein D. L., Galea E., Gavrilyuk V., Brosnan C. F., Whitacre C. C., Dumitrescu-Ozimek L., Landreth G. E., Pershadsingh H. A., Weinberg G., and, Heneka M. T., (2002) Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. 51, 694-702. (Pubitemid 34568847)
6. Furst S. M., Luedke D., Gaw H. H., Reich R., and, Gandolfi A. J., (1997) Demonstration of a cellular immune response in halothane-exposed guinea pigs. Toxicol. Appl. Pharmacol. 143, 245-255. (Pubitemid 27183543)
7. Guo F., Maeda Y., Ko E. M., et al,. (2012) Disruption of NMDA receptors in oligodendroglial lineage cells does not alter their susceptibility to experimental autoimmune encephalomyelitis or their normal development. J. Neurosci. 32, 639-645.
8. Han J., Kim N., and, Kim E., (2001) Trifluoroacetic acid activates ATP-sensitive K(+) channels in rabbit ventricular myocytes. Biochem. Biophys. Res. Commun. 285, 1136-1142. (Pubitemid 32912898)
9. Heneka M. T., Sharp A., Murphy P., Lyons J. A., Dumitrescu L., and, Feinstein D. L., (2001) The heat shock response reduces myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in mice. J. Neurochem. 77, 568-579. (Pubitemid 32298751)
10. Ji Z., Ke Z. J., and, Geng J. G., (2012) SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunol. Cell Biol. 90, 388-395.
11. Johns T. G., Kerlero de R. N., Menon K. K., Abo S., Gonzales M. F., and, Bernard C. C., (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154, 5536-5541.
12. Kim S. S., Richman D. P., Zamvil S. S., and, Agius M. A., (2011) Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice. J. Neurol. Sci. 306, 9-15.
13. Kuwabara T., Ishikawa F., Yasuda T., Aritomi K., Nakano H., Tanaka Y., Okada Y., Lipp M., and, Kakiuchi T., (2009) CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. J. Immunol. 183, 2513-2521.
14. Ma T. G., Ling Y. H., McClure G. D., and, Tseng M. T., (1990) Effects of trifluoroacetic acid, a halothane metabolite, on C6 glioma cells. J. Toxicol. Environ. Health 31, 147-158. (Pubitemid 20364598)
15. Malipiero U., Frei K., Spanaus K. S., Agresti C., Lassmann H., Hahne M., Tschopp J., Eugster H. P., and, Fontana A., (1997) Myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient lpr and gld mice. Eur. J. Immunol. 27, 3151-3160. (Pubitemid 28018009)
16. Mendel I., de Kerlero R., and, N. and Ben-Nun A., (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 25, 1951-1959.
17. Naves R., Singh S. P., Cashman K. S., Rowse A. L., Axtell R. C., Steinman L., Mountz J. D., Steele C., De S. P., and, Raman C., (2013) The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 191, 2967-2977.
18. Polak P. E., Kalinin S., Dello R. C., Gavrilyuk V., Sharp A., Peters J. M., Richardson J., Willson T. M., Weinberg G., and, Feinstein D. L., (2005) Protective effects of a peroxisome proliferator-activated receptor-beta/delta agonist in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 168, 65-75. (Pubitemid 41396404)
19. Polak P. E., Dull R. O., Kalinin S., Sharp A. J., Ripper R., Weinberg G., Schwartz D. E., Rubinstein I., and, Feinstein D. L., (2012a) Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis. J. Neuroinflammation 9, 272.
20. Polak P. E., Kalinin S., Braun D., Sharp A., Lin S. X., and, Feinstein D. L., (2012b) The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus. J. Neurochem. 121, 206-216.
21. Ransohoff R. M., (2012) Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 15, 1074-1077.
22. Recks M. S., Addicks K., and, Kuerten S., (2011) Spinal cord histopathology of MOG peptide 35-55-induced experimental autoimmune encephalomyelitis is time- and score-dependent. Neurosci. Lett. 494, 227-231.
23. Ren Z., Wang Y., Tao D., Liebenson D., Liggett T., Goswami R., Clarke R., Stefoski D., and, Balabanov R., (2011) Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis. J. Neurosci. 31, 8329-8341.
24. Ruffini F., Rossi S., Bergamaschi A., et al,. (2012) Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis. Mult. Scler. 19, 1084-1094.
25. Ryan K. R., McCue D., and, Anderton S. M., (2005) Fas-mediated death and sensory adaptation limit the pathogenic potential of autoreactive T cells after strong antigenic stimulation. J. Leukoc. Biol. 78, 43-50. (Pubitemid 40979942)
26. Satoh H., Fukuda Y., Anderson D. K., Ferrans V. J., Gillette J. R., and, Pohl L. R., (1985) Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J. Pharmacol. Exp. Ther. 233, 857-862. (Pubitemid 15024460)
27. Schluesener H. J., Sobel R. A., Linington C., and, Weiner H. L., (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139, 4016-4021. (Pubitemid 18013691)
28. Sestero C. M., McGuire D. J., De S. P., Brantley E. C., Soldevila G., Axtell R. C., and, Raman C., (2012) CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. J. Immunol. 189, 2918-2930.
29. Sharp A. J., Polak P. E., Simonini V., Lin S. X., Richardson J. C., Bongarzone E. R., and, Feinstein D. L., (2008) P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J. Neuroinflammation 5, 33.
30. Simonini M. V., Polak P. E., Sharp A., McGuire S., Galea E., and, Feinstein D. L., (2010) Increasing CNS noradrenaline reduces EAE severity. J. Neuroimmune. Pharmacol. 5, 252-259.
31. Stefferl A., Brehm U., and, Linington C., (2000) The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neural Transm. Suppl. 58, 123-133.
32. Suen W. E., Bergman C. M., Hjelmstrom P., and, Ruddle N. H., (1997) A critical role for lymphotoxin in experimental allergic encephalomyelitis. J. Exp. Med. 186, 1233-1240. (Pubitemid 27469018)
33. Suvannavejh G. C., Dal Canto M. C., Matis L. A., and, Miller S. D., (2000) Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J. Clin. Invest. 105, 223-231. (Pubitemid 30054362)
34. Tipps M. E., Iyer S. V., and, John M. S., (2012) Trifluoroacetate is an allosteric modulator with selective actions at the glycine receptor. Neuropharmacology 63, 368-373.
35. Trudell J. R., Ardies C. M., and, Anderson W. R., (1991) Antibodies raised against trifluoroacetyl-protein adducts bind to N-trifluoroacetyl- phosphatidylethanolamine in hexagonal phase phospholipid micelles. J. Pharmacol. Exp. Ther. 257, 657-662.
36. You Q., Cheng L., Reilly T. P., Wegmann D., and, Ju C., (2006) Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology 44, 1421-1431. (Pubitemid 44953648)
37. You Q., Cheng L., and, Ju C., (2010) Generation of T cell responses targeting the reactive metabolite of halothane in mice. Toxicol. Lett. 194, 79-85.
38. Zaheer S., Wu Y., Yang X., Ahrens M., Sahu S. K., and, Zaheer A., (2012) Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor. Neurochem. Int. 60, 215-219.
39. Zhang G. X., Yu S., Gran B., Li J., Calida D., Ventura E., Chen X., and, Rostami A., (2004) T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice. J. Neuroimmunol. 148, 1-10. (Pubitemid 38229553)